On Oct. 29, 2004, the U.S. Food and Drug Administration (FDA) approved Letrozole for the extended adjuvant treatment…
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
On Jan. 9, 2004, the Food and Drug Administration (FDA) announced the approval of Sanofi’s Eloxatin (oxaliplatin) injection…
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
In 2004, the Oklahoma Medical Research Foundation (OMRF) opened the state’s first small animal magnetic resonance imaging facility….
In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Oct. 9, 2003, The Scripps Research Institute (TSRI) announced the establishment of a major science center in…
On Sept. 4, 2003, the National Center for Research Resources (NCCR) awarded a $6.7 million grant to the…
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
On May 1, 2003, Mark Haddon’s The Curious Incident of the Dog in the Night-Time was published, allowing…
On Apr. 14, 2003, The International Human Genome Sequencing Consortium, led in the U.S. the National Human Genome…
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
On Mar. 4, 2003, Beth Israel Deaconess researchers pinpointed the source of preeclampsia, a life-threatening complication of pregnancy….
On Jan. 26, 2003, President Bush, in his State of the Union Address, announced the Emergency Plan for…
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
In 2003, the Medical University of South Carolina and Clemson University established a joint Bioengineering Program. Located on…
On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…
In Sept. 2002, the Alberta Innovates Centre for Carbohydrate Science (now Alberta Glycomics Centre), began operation with a…
On Jul. 9, 2002, the U.S. Centers for Disease Control and Prevention (CDC) reported newborn HIV infection reductions…
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
In February 2002, the doors opened to the John Stroger Hospital of Cook County, a new state-of-the-art, 464-bed,…